P

Inventor

BRANDT GARY E L

US22 patents
⚠️ This page may combine multiple inventors who share the name “BRANDT GARY E L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERAVANCE BIOPHARMA R&D IP LLC

20 patents
US10196393B2Feb 5, 2019

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC24 citations98
US10550118B2Feb 4, 2020

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC13 citations94
US10526330B2Jan 7, 2020

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC15 citations94
US10519153B2Dec 31, 2019

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC16 citations94
US10392386B2Aug 27, 2019

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC19 citations94
US10208040B2Feb 19, 2019

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC24 citations94
US9725470B2Aug 8, 2017

Substituted naphthyridines as JAK kinase inhibitors

THERAVANCE BIOPHARMA R&D IP LLC27 citations93
US10308646B2Jun 4, 2019

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC11 citations92
US11420965B2Aug 23, 2022

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US11254669B2Feb 22, 2022

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10954237B2Mar 23, 2021

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC2 citations84
US10562894B2Feb 18, 2020

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC7 citations84
US10913740B2Feb 9, 2021

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC5 citations83
US11453668B2Sep 27, 2022

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11299492B2Apr 12, 2022

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US12358931B2Jul 15, 2025

3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US12172994B2Dec 24, 2024

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11878977B2Jan 23, 2024

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11718616B2Aug 8, 2023

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11667637B2Jun 6, 2023

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC0 citations62

DECIPHERA PHARMACEUTICALS LLC

1 patent

THERAVANCE BIOPHARMA R & D IP LLC

1 patent